CANF
Can Fite Biopharma Ltd ADR
NYSE MKT: CANF · HEALTHCARE · BIOTECHNOLOGY
$3.10
+3.68% today
Updated 2026-04-30
Market cap
$6.23M
P/E ratio
—
P/S ratio
15.39x
EPS (TTM)
$-10.75
Dividend yield
—
52W range
$3 – $24
Volume
1.4M
Can Fite Biopharma Ltd ADR (CANF) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |